PERSONALIZED POSSIBILITIES Trademark

Trademark Overview


On Tuesday, May 7, 2013, a trademark application was filed for PERSONALIZED POSSIBILITIES with the United States Patent and Trademark Office. The USPTO has given the PERSONALIZED POSSIBILITIES trademark a serial number of 85925624. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 28, 2017. This trademark is owned by Abbott Molecular Inc.. The PERSONALIZED POSSIBILITIES trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Promoting pharmacogenomics, molecular diagnostics and companion diagnostics goods and services of others; consulting regarding regulatory matters, namely, clinical data and regulatory submission management and strategic counseling related to clinical testing, review and approval of diagnostic tests paired with specific therapies, in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics; retail store and wholesale store services featuring diagnostic test kits; retail store and wholesale store services featuring diagnostic reagents; retail store and wholesale store services featuring diagnostic kits composed of DNA probes, reagents and antibodies; retail store and wholesale store services featuring test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; retail store and wholesale store services featuring test and collection devices and kits for identification of nucleic ac...

Scientific and technological research and development services in the areas of pharmacogenomics, molecular diagnostics and companion diagnostics; development of companion diagnostics; Pharmacogenomics research services, namely, biomarker discovery services; molecular diagnostic research services; companion diagnostics research and development of medical tests for diagnosis and treatment; providing information relating to pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes; providing a website featuring information in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes; consulting in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes

Pharmacogenomics services, namely, medical testing for diagnostic or treatment purposes; molecular diagnostics services, namely, medical testing for diagnostic or treatment purposes; companion diagnostics services, namely, medical testing for diagnostic or treatment purposes and managing patient medical testing, namely, medical diagnostic testing monitoring and reporting services; providing information relating to pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes; providing a website featuring information in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes; consulting in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes
personalized possibilities

General Information


Serial Number85925624
Word MarkPERSONALIZED POSSIBILITIES
Filing DateTuesday, May 7, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 28, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2014

Trademark Statements


Disclaimer with Predetermined Text"PERSONALIZED"
Goods and ServicesPromoting pharmacogenomics, molecular diagnostics and companion diagnostics goods and services of others; consulting regarding regulatory matters, namely, clinical data and regulatory submission management and strategic counseling related to clinical testing, review and approval of diagnostic tests paired with specific therapies, in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics; retail store and wholesale store services featuring diagnostic test kits; retail store and wholesale store services featuring diagnostic reagents; retail store and wholesale store services featuring diagnostic kits composed of DNA probes, reagents and antibodies; retail store and wholesale store services featuring test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; retail store and wholesale store services featuring test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; retail store and wholesale store services featuring computer software and hardware in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics
Goods and ServicesScientific and technological research and development services in the areas of pharmacogenomics, molecular diagnostics and companion diagnostics; development of companion diagnostics; Pharmacogenomics research services, namely, biomarker discovery services; molecular diagnostic research services; companion diagnostics research and development of medical tests for diagnosis and treatment; providing information relating to pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes; providing a website featuring information in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes; consulting in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes
Goods and ServicesPharmacogenomics services, namely, medical testing for diagnostic or treatment purposes; molecular diagnostics services, namely, medical testing for diagnostic or treatment purposes; companion diagnostics services, namely, medical testing for diagnostic or treatment purposes and managing patient medical testing, namely, medical diagnostic testing monitoring and reporting services; providing information relating to pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes; providing a website featuring information in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes; consulting in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, May 14, 2013
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 14, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 14, 2013
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbbott Molecular Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDes Plaines, IL 60018

Party NameAbbott Molecular Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDes Plaines, IL 60018

Trademark Events


Event DateEvent Description
Monday, August 28, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 28, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 31, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 30, 2017EXTENSION 5 GRANTED
Monday, January 23, 2017EXTENSION 5 FILED
Monday, January 23, 2017TEAS EXTENSION RECEIVED
Saturday, July 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 29, 2016EXTENSION 4 GRANTED
Thursday, July 21, 2016EXTENSION 4 FILED
Thursday, July 21, 2016TEAS EXTENSION RECEIVED
Tuesday, February 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 1, 2016EXTENSION 3 GRANTED
Thursday, January 21, 2016EXTENSION 3 FILED
Thursday, January 21, 2016TEAS EXTENSION RECEIVED
Thursday, July 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 29, 2015EXTENSION 2 GRANTED
Wednesday, July 22, 2015EXTENSION 2 FILED
Wednesday, July 22, 2015TEAS EXTENSION RECEIVED
Thursday, March 12, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 11, 2015EXTENSION 1 GRANTED
Thursday, January 22, 2015EXTENSION 1 FILED
Tuesday, March 10, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 22, 2015TEAS EXTENSION RECEIVED
Tuesday, July 22, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 28, 2014NOTICE OF PUBLICATION
Tuesday, May 27, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 27, 2014PUBLISHED FOR OPPOSITION
Wednesday, May 7, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 21, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, April 19, 2014ASSIGNED TO LIE
Friday, March 28, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 21, 2014EXAMINER'S AMENDMENT ENTERED
Friday, March 21, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 21, 2014EXAMINERS AMENDMENT E-MAILED
Friday, March 21, 2014EXAMINERS AMENDMENT -WRITTEN
Saturday, March 1, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 28, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 28, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 30, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 30, 2013NON-FINAL ACTION E-MAILED
Friday, August 30, 2013NON-FINAL ACTION WRITTEN
Saturday, August 24, 2013ASSIGNED TO EXAMINER
Tuesday, May 14, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 10, 2013NEW APPLICATION ENTERED IN TRAM